New Avenues in Phelan-McDermid Syndrome Research Featuring Drs. Boaz Barak and Haitham Amal
Description
In this exciting combo episode about new avenues in Phelan-McDermid syndrome research, Dr. Lauren speaks with Dr. Boaz Barak from Tel Aviv University and Dr. Haitham Amal from Hebrew University/Boston Children's Hospital.
Dr. Barak describes his work on understanding the process of myelination, where "electrical cables" help brain cells to communicate, and how SHANK3 is involved in this process. He also discusses his lab's work on possible treatments for Phelan-McDermid syndrome. Dr. Barak's work was recently awarded Autism Science Foundation's Profound Autism Pilot Grants! Read more here: https://autismsciencefoundation.org/asf-funded-research/
Dr. Amal explains why nitric oxide (NO) is important for brain functioning and how NO is linked to autism as well as Phelan-McDermid Syndrome. He also describes his ongoing work with the two companies that he co-founded, NeuroNOS and Point6 Bio. NeurNOS's lead investigational therapy, BA-102, for the treatment of Phelan-McDermid Syndrome (PMS) just received Orphan Drug status from the FDA! Learn more here: https://www.neuro-nos.com/oddpms
Don't forget to subscribe wherever you get your podcasts to discover groundbreaking research uncovering new paths in understanding and treating Phelan-McDermid Syndrome — hope and progress are on the horizon!
United States
